MK-3402
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-3402, covering 2022-11-04 to 2022-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004) [Phase 1]